A Current Status and Future Prospects of Nanotechnology in Diagnostic Imaging
Antra Arora
Amity Institute of Applied Sciences, Amity University Noida, Uttar Pradesh, India
Diagnostic imaging refers to a broad batch of technologies used to examine the body in order to diagnose different diseases. The quick pace of the present world has given rise to a few threats in the field of healthcare. Depression, hypertension, diabetes, tumors and a few contagious diseases are only a fraction of the common issues related to the rapid stress-filled lifestyle. Early disease detection even before symptoms’ presence, improved imaging of internal body structure, as well as ease of diagnostic procedures, have been developed with the help of a new branch of laboratory medicine termed as Nano diagnostics. Nanotechnology can improve diagnostic imaging techniques even at the level of single cells before overall symptoms appear. Fusion of nanomaterials with molecular imaging devices permits diagnostic and dynamic processes at the molecular level . Many imaging technologies, for example, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) and Positron Emission Topography (PET) depend on intravenously administered contrast agents. While the present age of contrast agents has facilitated fast analysis, yet they experience the ill effects of numerous unwanted defects including an absence of tissue specificity and systemic toxicity issues. In this report, we present an outline of the leading technologies presently used for diagnostic imaging and the manner in which nanotechnology is used to upgrade these methods
Key Words: Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) and Positron Emission Topography (PET).
………………………………………………………………………………………………………
References :
[1] Wickline S.A., Lanza G.M. ;Molecular Imaging, Targeted Therapeutics, and Nanoscience; J
Cellular Biochem Supp, 39 (2002) 90–97
[2] K. Rajasundari and K. Ilamurugu; Nanotechnology and Its Applications in Medical Diagnosis; J. Basic. Appl. Chem., 1(2011)26-32.
[3] Pan D, Lanza GM, Wickline SA ; Nanomedicine: perspective and promises with ligand-directed molecular imaging; European J Radiol ,70 (2009) 274-285
